887 related articles for article (PubMed ID: 2476204)
1. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
2. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
3. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
[TBL] [Abstract][Full Text] [Related]
4. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
Radikov N
Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
[TBL] [Abstract][Full Text] [Related]
5. [Expression of human chorionic gonadotropin, human placental lactogen and pregnancy-specific 1-glycoprotein in malignant trophoblastic neoplasms].
Xiong YY; Zeng J; Tang ZJ
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):610-3, 638. PubMed ID: 7712876
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
7. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
Sakuragi N
Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
[No Abstract] [Full Text] [Related]
8. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
[TBL] [Abstract][Full Text] [Related]
9. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
11. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro studies on the production of placental proteins (human chorionic gonadotropin, human placental lactogen, and pregnancy-specific beta 1-glycoprotein) in an adrenal choriocarcinoma.
Maeyama M; Furuki Y; Munemura M; Tanaka N; Iwamasa T
Obstet Gynecol; 1985 Apr; 65(4):593-6. PubMed ID: 3872425
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
Rutanen EM; Seppälä M
J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
[No Abstract] [Full Text] [Related]
14. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
Ozturk M
J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
[TBL] [Abstract][Full Text] [Related]
15. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
16. Schwangerschaftsprotein 1 (SP1) in serum and cerebrospinal fluid of patients with gestational trophoblastic disease.
Ho PC; Ma HK
Br J Obstet Gynaecol; 1983 Apr; 90(4):317-22. PubMed ID: 6188478
[TBL] [Abstract][Full Text] [Related]
17. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
18. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
19. [The laboratory in monitoring high-risk pregnancy].
Radillo L; Cociancich G; D'Atri A; Ghionni A; Mangiarotti M
Quad Sclavo Diagn; 1981 Jun; 17(2):164-71. PubMed ID: 6973774
[TBL] [Abstract][Full Text] [Related]
20. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]